Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Here, color refers to the pen casing and label, not the liquid inside
What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation
On ne sait pas encore clairement si cet avantage lemporte sur les risques (voir plus loin)
PMID: 34417390
Doses are given once per week, ideally on the same day and time
US$ 27.70
US$ 22.33
US$ 26.82
US$ 24.12
US$ 28.48
US$ 22.06
US$ 26.22
US$ 24.17
US$ 21.08
US$ 25.37
%20(1).png)
